JP2023537958A5 - - Google Patents
Info
- Publication number
- JP2023537958A5 JP2023537958A5 JP2023509554A JP2023509554A JP2023537958A5 JP 2023537958 A5 JP2023537958 A5 JP 2023537958A5 JP 2023509554 A JP2023509554 A JP 2023509554A JP 2023509554 A JP2023509554 A JP 2023509554A JP 2023537958 A5 JP2023537958 A5 JP 2023537958A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- variable domain
- single variable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010842370.5 | 2020-08-20 | ||
| CN202010842370 | 2020-08-20 | ||
| PCT/CN2021/112756 WO2022037527A1 (zh) | 2020-08-20 | 2021-08-16 | 结合bcma的单可变结构域及抗原结合分子 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023537958A JP2023537958A (ja) | 2023-09-06 |
| JP2023537958A5 true JP2023537958A5 (cg-RX-API-DMAC7.html) | 2024-08-26 |
| JP7821159B2 JP7821159B2 (ja) | 2026-02-26 |
Family
ID=80323410
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023509554A Active JP7821159B2 (ja) | 2020-08-20 | 2021-08-16 | Bcmaと結合する単一可変ドメイン及び抗原結合分子 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US12612635B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4202047A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7821159B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230045066A (cg-RX-API-DMAC7.html) |
| CN (1) | CN115715325A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022037527A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20230170721A (ko) * | 2021-04-15 | 2023-12-19 | 치아타이 티안큉 파마수티컬 그룹 주식회사 | Bcma를 표적으로 하는 다중 특이성 항체 |
| EP4719352A1 (en) | 2023-05-31 | 2026-04-08 | Capstan Therapeutics, Inc. | Lipid nanoparticle formulations and compositions |
| WO2025076113A1 (en) | 2023-10-05 | 2025-04-10 | Capstan Therapeutics, Inc. | Ionizable cationic lipids with conserved spacing and lipid nanoparticles |
| US20250127728A1 (en) | 2023-10-05 | 2025-04-24 | Capstan Therapeutics, Inc. | Constrained Ionizable Cationic Lipids and Lipid Nanoparticles |
| WO2025217452A1 (en) | 2024-04-11 | 2025-10-16 | Capstan Therapeutics, Inc. | Constrained ionizable cationic lipids and lipid nanoparticles |
| WO2025217454A2 (en) | 2024-04-11 | 2025-10-16 | Capstan Therapeutics, Inc. | Ionizable cationic lipids and lipid nanoparticles |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002238052A1 (en) * | 2001-02-20 | 2002-09-04 | Zymogenetics, Inc. | Antibodies that bind both bcma and taci |
| EP3974453A3 (en) * | 2010-11-16 | 2022-08-03 | Amgen Inc. | Agents and methods for treating diseases that correlate with bcma expression |
| TWI679212B (zh) * | 2011-11-15 | 2019-12-11 | 美商安進股份有限公司 | 針對bcma之e3以及cd3的結合分子 |
| US9243058B2 (en) * | 2012-12-07 | 2016-01-26 | Amgen, Inc. | BCMA antigen binding proteins |
| BR112016024546A2 (pt) * | 2014-04-30 | 2018-01-23 | Max-Delbrück-Centrum Für Molekulare Medizin In Der Helmholtz-Gemeinschaft | anticorpo ou fragmento de anticorpo, anticorpo ou fragmento de anticorpo isolado, conjugado de anticorpo-fármaco, molécula de ácido nucleico, célula hospedeira, e, composição farmacêutica |
| TWI700298B (zh) * | 2015-04-13 | 2020-08-01 | 美商輝瑞股份有限公司 | 靶向b細胞成熟抗原之嵌合型抗原受體類 |
| PL3896091T3 (pl) | 2016-08-10 | 2024-04-29 | Legend Biotech Ireland Limited | Chimeryczne receptory antygenowe nakierowane na bcma i sposoby ich zastosowania |
| WO2019066435A2 (ko) | 2017-09-29 | 2019-04-04 | 재단법인 목암생명과학연구소 | Bcma에 높은 친화도를 가지는 항-bcma 항체 및 이를 포함하는 암 치료용 약학적 조성물 |
| PE20210320A1 (es) | 2018-06-01 | 2021-02-16 | Novartis Ag | Moleculas de union contra bcma y usos de las mismas |
| CN111542343B (zh) * | 2018-08-24 | 2023-08-18 | 上海先博生物科技有限公司 | 抗bcma的单域抗体及其应用 |
| CN109942708B (zh) * | 2019-03-28 | 2021-01-05 | 上海科棋药业科技有限公司 | 一种抗bcma的单域抗体及其应用 |
| CN109942709B (zh) * | 2019-04-22 | 2019-12-27 | 广州百暨基因科技有限公司 | 一种抗bcma的单域抗体及其应用 |
| CN111333729B (zh) | 2020-03-17 | 2022-12-06 | 深圳市南科生物工程有限公司 | 抗b细胞成熟抗原的纳米抗体及应用 |
| KR20230170721A (ko) | 2021-04-15 | 2023-12-19 | 치아타이 티안큉 파마수티컬 그룹 주식회사 | Bcma를 표적으로 하는 다중 특이성 항체 |
-
2021
- 2021-08-16 WO PCT/CN2021/112756 patent/WO2022037527A1/zh not_active Ceased
- 2021-08-16 CN CN202180041380.1A patent/CN115715325A/zh active Pending
- 2021-08-16 JP JP2023509554A patent/JP7821159B2/ja active Active
- 2021-08-16 KR KR1020237007603A patent/KR20230045066A/ko active Pending
- 2021-08-16 EP EP21857622.1A patent/EP4202047A4/en active Pending
- 2021-08-16 US US18/020,578 patent/US12612635B2/en active Active